These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1197247)

  • 41. [Prognostic significance of programmed dialysis in patients who initiate renal substitutive treatment. Multicenter study in Spain].
    Górriz JL; Sancho A; Pallardó LM; Amoedo ML; Martín M; Sanz P; Barril G; Selgas R; Salgueira M; Palma A; de la Torre M; Ferreras I
    Nefrologia; 2002; 22(1):49-59. PubMed ID: 11987685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Non-machinery dialysis].
    Uehara H; Shiohira Y; Sunagawa H; Akamine S
    Nihon Rinsho; 1991 Dec; 49 Suppl():377-81. PubMed ID: 1808286
    [No Abstract]   [Full Text] [Related]  

  • 43. [Research on a new dialytic strategy].
    Orlandini G; Baraldi A; Cappelli G; Landini S; Malmusi G; Savazzi A; Vandelli L; Lusvarghi E; Bigi L; Barbieri L
    Minerva Nefrol; 1979; 26(3):415-8. PubMed ID: 262285
    [No Abstract]   [Full Text] [Related]  

  • 44. Quantifying the discontinuity of haemodialysis dose with time-averaged concentration (TAC) and time-averaged deviation (TAD).
    Korohoda P; Pietrzyk JA; Schneditz D
    Nephrol Dial Transplant; 2010 Mar; 25(3):1011-2; author reply 1012. PubMed ID: 20054023
    [No Abstract]   [Full Text] [Related]  

  • 45. Short-term dialysis--long-term complications. Ten years experience with short-duration renal replacement therapy.
    Wizemann V; Kramer W
    Blood Purif; 1987; 5(4):193-201. PubMed ID: 3426827
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of therapy time and frequency on effective solute removal.
    Pierratos A
    Semin Dial; 2001; 14(4):284-8. PubMed ID: 11489204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The treatment of chronic renal insufficiency by repeated perfusion of an isolated small intestinal loop].
    HEINTZ R; RENNER D; MINNER W
    Dtsch Med Wochenschr; 1961 Apr; 86():813-9. PubMed ID: 13712972
    [No Abstract]   [Full Text] [Related]  

  • 48. [New results of studies on the choice of cardiac glycosides for patients under dialysis].
    Kramer P; Langescheid C; Köthe E; Scheler F
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1669-72. PubMed ID: 1030075
    [No Abstract]   [Full Text] [Related]  

  • 49. First-choice vascular access in patients over 65 years of age starting dialysis.
    Gómez Campderá FJ; Polo JR; Sanabia J; Tejedor A
    Nephron; 1996; 73(2):342-3. PubMed ID: 8773380
    [No Abstract]   [Full Text] [Related]  

  • 50. Advances in chronic kidney disease 2009. Proceedings of the 11th International Conference on Dialysis. January 28-30, 2009. Las Vegas, Nevada, USA.
    Blood Purif; 2009; 27(1):5-134. PubMed ID: 19353760
    [No Abstract]   [Full Text] [Related]  

  • 51. [Problems of kidney biopsy and dialysis as demonstrated by three cases of severe acute anuria].
    EFFERSØE P; GORMSEN H; IVERSEN P; RAASCHOU F
    Ugeskr Laeger; 1954 Dec; 116(49):1715-28. PubMed ID: 13238420
    [No Abstract]   [Full Text] [Related]  

  • 52. Programmed instruction: an approach to dietary management of dialysis patients.
    Freeman RM; Bulechek GM
    Am J Clin Nutr; 1968 Jun; 21(6):613-7. PubMed ID: 5666638
    [No Abstract]   [Full Text] [Related]  

  • 53. Uraemic neuropathy.
    Lancet; 1966 Apr; 1(7440):749. PubMed ID: 4159727
    [No Abstract]   [Full Text] [Related]  

  • 54. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [2 1/2-year experience with highly-effective short-term dialyses in Erfurt].
    Otto N; Thieler H; Schmidt U; Marx M
    Z Urol Nephrol; 1978 May; 71(5):323-7. PubMed ID: 676536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short time personalised dialysis: good results in spite of high levels of small and middle molecules.
    Maiorca R; Castellani A; Migozzi G; Panzetta GO; Usberti M
    Proc Eur Dial Transplant Assoc; 1975; 11():146-52. PubMed ID: 1197247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From adequate to optimal dialysis long 3 x 8 hr dialysis: a reasonable compromise.
    Charra B
    Nefrologia; 2005; 25 Suppl 2():19-24. PubMed ID: 16050397
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.